These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 652447)

  • 1. [Defibrinating treatment in children with severe nephrotic syndrome].
    Grygalewicz J; Ostojska J
    Pediatr Pol; 1978 Apr; 53(4):531-6. PubMed ID: 652447
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reduction of hyperfibrinemia in the nephrotic syndrome using defibrase].
    Salvadori JM; Follana R; Olmer M
    J Urol Nephrol (Paris); 1975 Sep; 81(9):691-6. PubMed ID: 1214313
    [No Abstract]   [Full Text] [Related]  

  • 3. Defibrinating agents: effects on blood rheology, blood flow and vascular diseases in controlled studies.
    Lowe GD
    Bibl Haematol; 1981; (47):247-51. PubMed ID: 7039612
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic lowering of fibrinogen levels].
    Ernst E
    MMW Munch Med Wochenschr; 1983 May; 125(21):83-4. PubMed ID: 6410202
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. A critical analysis].
    Ernst E
    MMW Munch Med Wochenschr; 1983 Sep; 125(37):796-8. PubMed ID: 6415441
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic defibrinogenation in peripheral vascular disease.
    Ernst E
    Int Angiol; 1985; 4(3):373-7. PubMed ID: 3913715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical treatment of retinal venous occlusions with a new defibrinating agent (Defibrase). Preliminary study].
    Gaudric A; Tolub O; Coscas G; Conard J; Samama M; Lelong F
    Bull Soc Ophtalmol Fr; 1982 Jan; 82(1):79-82. PubMed ID: 7049431
    [No Abstract]   [Full Text] [Related]  

  • 8. [Defibrination-therapy using a thrombin-like snake venom enzyme (Defibrase) Blood-coagulation physiological studies and clinical experiences].
    Martin M; Engelken HJ; Tambert F; Martin U; Hirdes E; Auel H
    Vasa Suppl; 1976; 5():1-39. PubMed ID: 1070197
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of various anti-platelet drugs and defibrinating agents on experimental glomerulonephritis in rats (author's transl)].
    Ogawa S; Naruse T
    Nihon Jinzo Gakkai Shi; 1981 Mar; 23(3):309-22. PubMed ID: 7031320
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of defibrinating enzymes in the treatment of chronic ischemia of lower extremities].
    Malanowicz W; Liszewska D; Skarzyńska M; Tymińska K; Latallo ZS
    Pol Arch Med Wewn; 1977 Jul; 58(1):23-31. PubMed ID: 887461
    [No Abstract]   [Full Text] [Related]  

  • 11. [The therapeutic effect of defibrase on patients with an acute stage of chronic cor pulmonale].
    Zhou YC; Weng XZ; Qiu HG
    Zhonghua Nei Ke Za Zhi; 1986 Jul; 25(7):404-6, 444. PubMed ID: 3542425
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fibrinolytics and defibrinating agents].
    Vergoz D
    Phlebologie; 1975; 28(1):37-8. PubMed ID: 1202531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Klobusitzky's hemocoagulasis in the treatment of hemorrhage in pediatrics].
    Biscatti G; Bruschelli M; Bianchi E
    Minerva Pediatr; 1975 Mar; 27(7):449-52. PubMed ID: 1143228
    [No Abstract]   [Full Text] [Related]  

  • 14. Defibrinogating therapy for peripheral circulatory disturbance in patients with vibration syndrome.
    Nasu Y
    Scand J Work Environ Health; 1986 Aug; 12(4 Spec No):272-6. PubMed ID: 3535061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodilution combined with defibrinogenation.
    Böhme H; Everts B
    Bibl Haematol; 1981; (47):165-72. PubMed ID: 7039611
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antimetastatic effect of batroxobin].
    Shibuya M; Aoyama A; Kawachi S; Baba M; Murata A; Sakai S; Ohtsuka M; Matsusaka M; Niitani H
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):732-4. PubMed ID: 3548597
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemocoagulant effect of Topical Reptilase].
    Sigurta D
    Dent Cadmos; 1986 Oct; 54(15):87-9. PubMed ID: 3552764
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of anticoagulation methods available for extracorporeal circulation in the dog].
    Legendre L; Guidoin R; Martin L; Blais P; Marois M; Roy J; Awad J
    Union Med Can; 1980 Mar; 109(3):387-96. PubMed ID: 6990575
    [No Abstract]   [Full Text] [Related]  

  • 19. [The treatment of herpes zoster with hemocoagulase (Bothrops Jararaca venom)].
    De Candia O; Baghiris D
    Clin Ter; 1979 Jun; 89(6):589-93. PubMed ID: 397028
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on blood coagulation systems during defibrinogenation therapy with batroxobin (Bothrops atrox venom) (author's transl)].
    Ishimaru S; Konishi M; Furukawa K; Takahashi M; Fujimaki M
    Rinsho Ketsueki; 1979 May; 20(5):500-9. PubMed ID: 465131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.